VIRBAC SA (VIRP.PA) Fundamental Analysis & Valuation

EPA:VIRP • FR0000031577

Current stock price

373 EUR
-5.5 (-1.45%)
Last:

This VIRP.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. VIRP.PA Profitability Analysis

1.1 Basic Checks

  • In the past year VIRP was profitable.
  • VIRP had a positive operating cash flow in the past year.
  • In the past 5 years VIRP has always been profitable.
  • Each year in the past 5 years VIRP had a positive operating cash flow.
VIRP.PA Yearly Net Income VS EBIT VS OCF VS FCFVIRP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M 250M

1.2 Ratios

  • VIRP's Return On Assets of 7.88% is fine compared to the rest of the industry. VIRP outperforms 63.27% of its industry peers.
  • The Return On Equity of VIRP (13.41%) is comparable to the rest of the industry.
  • Looking at the Return On Invested Capital, with a value of 11.43%, VIRP is in the better half of the industry, outperforming 61.22% of the companies in the same industry.
Industry RankSector Rank
ROA 7.88%
ROE 13.41%
ROIC 11.43%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VIRP.PA Yearly ROA, ROE, ROICVIRP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 10.30%, VIRP is in line with its industry, outperforming 46.94% of the companies in the same industry.
  • VIRP's Profit Margin has declined in the last couple of years.
  • VIRP has a Operating Margin (15.71%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of VIRP has grown nicely.
  • The Gross Margin of VIRP (66.58%) is comparable to the rest of the industry.
  • VIRP's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.71%
PM (TTM) 10.3%
GM 66.58%
OM growth 3Y1.33%
OM growth 5Y3.81%
PM growth 3Y0.9%
PM growth 5Y-6.69%
GM growth 3Y13.46%
GM growth 5Y6.47%
VIRP.PA Yearly Profit, Operating, Gross MarginsVIRP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. VIRP.PA Health Analysis

2.1 Basic Checks

  • VIRP has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • VIRP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
VIRP.PA Yearly Shares OutstandingVIRP.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
VIRP.PA Yearly Total Debt VS Total AssetsVIRP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • VIRP has an Altman-Z score of 4.63. This indicates that VIRP is financially healthy and has little risk of bankruptcy at the moment.
  • VIRP's Altman-Z score of 4.63 is fine compared to the rest of the industry. VIRP outperforms 71.43% of its industry peers.
  • The Debt to FCF ratio of VIRP is 2.98, which is a good value as it means it would take VIRP, 2.98 years of fcf income to pay off all of its debts.
  • VIRP has a Debt to FCF ratio of 2.98. This is in the better half of the industry: VIRP outperforms 67.35% of its industry peers.
  • VIRP has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.16, VIRP is in the better half of the industry, outperforming 79.59% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 2.98
Altman-Z 4.63
ROIC/WACC1.48
WACC7.75%
VIRP.PA Yearly LT Debt VS Equity VS FCFVIRP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

  • VIRP has a Current Ratio of 1.53. This is a normal value and indicates that VIRP is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Current ratio value of 1.53, VIRP is doing good in the industry, outperforming 63.27% of the companies in the same industry.
  • A Quick Ratio of 0.80 indicates that VIRP may have some problems paying its short term obligations.
  • The Quick ratio of VIRP (0.80) is worse than 69.39% of its industry peers.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 0.8
VIRP.PA Yearly Current Assets VS Current LiabilitesVIRP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. VIRP.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 3.79% over the past year.
  • Measured over the past 5 years, VIRP shows a small growth in Earnings Per Share. The EPS has been growing by 2.23% on average per year.
  • Looking at the last year, VIRP shows a small growth in Revenue. The Revenue has grown by 4.82% in the last year.
  • The Revenue has been growing by 9.41% on average over the past years. This is quite good.
EPS 1Y (TTM)3.79%
EPS 3Y7.64%
EPS 5Y2.23%
EPS Q2Q%1335.35%
Revenue 1Y (TTM)4.82%
Revenue growth 3Y6.39%
Revenue growth 5Y9.41%
Sales Q2Q%4.64%

3.2 Future

  • VIRP is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.69% yearly.
  • VIRP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.98% yearly.
EPS Next Y12.72%
EPS Next 2Y11.49%
EPS Next 3Y10.55%
EPS Next 5Y6.69%
Revenue Next Year5.94%
Revenue Next 2Y5.84%
Revenue Next 3Y5.44%
Revenue Next 5Y5.98%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
VIRP.PA Yearly Revenue VS EstimatesVIRP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B
VIRP.PA Yearly EPS VS EstimatesVIRP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15 20 25

More info and screens

Find the best growth stocksShow best growing peers

2

4. VIRP.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 20.72 indicates a rather expensive valuation of VIRP.
  • The rest of the industry has a similar Price/Earnings ratio as VIRP.
  • The average S&P500 Price/Earnings ratio is at 27.35. VIRP is valued slightly cheaper when compared to this.
  • VIRP is valuated rather expensively with a Price/Forward Earnings ratio of 17.44.
  • VIRP's Price/Forward Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 22.23. VIRP is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 20.72
Fwd PE 17.44
VIRP.PA Price Earnings VS Forward Price EarningsVIRP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, VIRP is valued a bit cheaper than 65.31% of the companies in the same industry.
  • VIRP's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. VIRP is more expensive than 65.31% of the companies in the same industry.
Industry RankSector Rank
P/FCF 32.31
EV/EBITDA 11.47
VIRP.PA Per share dataVIRP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

  • VIRP's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.63
PEG (5Y)9.31
EPS Next 2Y11.49%
EPS Next 3Y10.55%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. VIRP.PA Dividend Analysis

5.1 Amount

  • VIRP has a yearly dividend return of 0.38%, which is pretty low.
  • VIRP's Dividend Yield is comparable with the industry average which is at 1.96.
  • Compared to an average S&P500 Dividend Yield of 1.82, VIRP's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.38%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years4
VIRP.PA Yearly Dividends per shareVIRP.PA Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

  • VIRP pays out 8.05% of its income as dividend. This is a sustainable payout ratio.
DP8.05%
EPS Next 2Y11.49%
EPS Next 3Y10.55%
VIRP.PA Yearly Income VS Free CF VS DividendVIRP.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M
VIRP.PA Dividend Payout.VIRP.PA Dividend Payout, showing the Payout Ratio.VIRP.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

VIRP.PA Fundamentals: All Metrics, Ratios and Statistics

VIRBAC SA

EPA:VIRP (4/27/2026, 7:00:00 PM)

373

-5.5 (-1.45%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)04-16
Earnings (Next)04-27
Inst Owners25.03%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap3.13B
Revenue(TTM)1.46B
Net Income(TTM)150.89M
Analysts82.5
Price Target421.37 (12.97%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.38%
Yearly Dividend1.32
Dividend Growth(5Y)N/A
DP8.05%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.53%
PT rev (3m)2.76%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.69%
EPS NY rev (3m)0.58%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)0.7%
Valuation
Industry RankSector Rank
PE 20.72
Fwd PE 17.44
P/S 2.14
P/FCF 32.31
P/OCF 15.73
P/B 2.78
P/tB 5.82
EV/EBITDA 11.47
EPS(TTM)18
EY4.83%
EPS(NY)21.39
Fwd EY5.73%
FCF(TTM)11.54
FCFY3.09%
OCF(TTM)23.72
OCFY6.36%
SpS174.57
BVpS134.11
TBVpS64.13
PEG (NY)1.63
PEG (5Y)9.31
Graham Number233.056 (-37.52%)
Profitability
Industry RankSector Rank
ROA 7.88%
ROE 13.41%
ROCE 16.46%
ROIC 11.43%
ROICexc 12.57%
ROICexgc 23.33%
OM 15.71%
PM (TTM) 10.3%
GM 66.58%
FCFM 6.61%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y1.33%
OM growth 5Y3.81%
PM growth 3Y0.9%
PM growth 5Y-6.69%
GM growth 3Y13.46%
GM growth 5Y6.47%
F-Score6
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 2.98
Debt/EBITDA 0.6
Cap/Depr 168.58%
Cap/Sales 6.97%
Interest Coverage 53.91
Cash Conversion 68.44%
Profit Quality 64.19%
Current Ratio 1.53
Quick Ratio 0.8
Altman-Z 4.63
F-Score6
WACC7.75%
ROIC/WACC1.48
Cap/Depr(3y)144.88%
Cap/Depr(5y)133.01%
Cap/Sales(3y)5.84%
Cap/Sales(5y)5.27%
Profit Quality(3y)81.35%
Profit Quality(5y)70.88%
High Growth Momentum
Growth
EPS 1Y (TTM)3.79%
EPS 3Y7.64%
EPS 5Y2.23%
EPS Q2Q%1335.35%
EPS Next Y12.72%
EPS Next 2Y11.49%
EPS Next 3Y10.55%
EPS Next 5Y6.69%
Revenue 1Y (TTM)4.82%
Revenue growth 3Y6.39%
Revenue growth 5Y9.41%
Sales Q2Q%4.64%
Revenue Next Year5.94%
Revenue Next 2Y5.84%
Revenue Next 3Y5.44%
Revenue Next 5Y5.98%
EBIT growth 1Y0.49%
EBIT growth 3Y7.81%
EBIT growth 5Y13.58%
EBIT Next Year39.29%
EBIT Next 3Y17.83%
EBIT Next 5Y14.53%
FCF growth 1Y-46.61%
FCF growth 3Y28.73%
FCF growth 5Y1.5%
OCF growth 1Y-24%
OCF growth 3Y26.21%
OCF growth 5Y10.85%

VIRBAC SA / VIRP.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of VIRBAC SA (VIRP.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to VIRP.PA.


What is the valuation status for VIRP stock?

ChartMill assigns a valuation rating of 2 / 10 to VIRBAC SA (VIRP.PA). This can be considered as Overvalued.


What is the profitability of VIRP stock?

VIRBAC SA (VIRP.PA) has a profitability rating of 5 / 10.


Can you provide the expected EPS growth for VIRP stock?

The Earnings per Share (EPS) of VIRBAC SA (VIRP.PA) is expected to grow by 12.72% in the next year.


Is the dividend of VIRBAC SA sustainable?

The dividend rating of VIRBAC SA (VIRP.PA) is 2 / 10 and the dividend payout ratio is 8.05%.